2022 in review
It has been another big year in pharmacy, and PDL is aware of the ongoing pressure Australian pharmacists have been under. The COVID-19 pandemic, staffing shortages, public aggression and workload issues are just some of the challenges pharmacists have faced. We would like to congratulate PDL members for the service you have continued to provide […]
Opioid Therapy Program management resources
As a PDL NSW member, you may have seen the Forum communique sent on 13 October 2022 regarding the joint initiative between the Pharmacy Council of NSW, NSW Health and the pharmacy organisations representing most NSW pharmacists. As mentioned in the communique, the purpose of the Forum is to: • monitor regulatory issues that impact […]
COVID-19 bivalent booster vaccines – important update
The recent availability of the Moderna Spikevax Bivalent Booster Vaccine has seen a rise in the number of vaccine-related calls and incident reports to PDL. With the availability of the Pfizer Comirnaty Bivalent Booster Vaccine imminent, the PDL Professional Officers would like to remind pharmacists of the need to review all vaccination procedures before offering […]
It’s that time of year – PBA registration renewal including insurance declaration
Each year, PDL receives calls from pharmacists who have overlooked their Pharmacy Board of Australia (PBA) registration renewal. This may happen due to renewal reminders being quarantined in junk or spam folders, or changes to email and postal addresses and mobile numbers. Ahpra attempts to contact lapsed registrants through all such means, but this can […]
National Vacancy for Professional Officer
Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 31,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession, PDL’s incident support service is dedicated to members around the clock, for confidential, expert advice. The professional indemnity policy for pharmacists provided by PDL covers everything in the scope of […]
Managing high-risk S8, S4B and S4D medicines
PDL NSW members were recently sent a Forum communique on 13 October 2022 regarding the joint initiative between the Pharmacy Council of NSW, NSW Health and the pharmacy organisations representing most NSW pharmacists. As mentioned in the communique, the purpose of the Forum is to: monitor regulatory issues that impact on the governance and performance […]
NSW Pharmacy Quarterly Stakeholder Forum 2022 – Communique
The Pharmacy Council of NSW has launched a new initiative involving a quarterly forum bringing together key pharmacy stakeholder agencies to discuss issues of relevance to the profession. The impetus for this initiative was an increase in complaints about pharmacists to the Health Care Complaints Commission and the Pharmacy Council. The specific purpose of the […]
A conversation with Amanda Galbraith
Our recently retired and newly appointed PDL Directors for the ACT and NSW, Curtis Ruhnau and Amanda Galbraith, sat down to discuss what has been happening in their space. Curtis Ruhnau: G’day Amanda, I remember when you were appointed to the PDL Board as the first female Director for NSW/ACT, and the first Director residing […]
UTIPP-Q pilot transition to EPA
Pharmacists practising in Queensland are advised the UTIPP-Q pilot has finished and the Urinary Tract Infection Community Pharmacy Service is now allowed under the Pharmacists Extended Practice Authority (EPA). Pharmacists and pharmacies can now offer the UTI service according to the provisions of the EPA. The following update from Professor Lisa Nissen on behalf of […]
Notice of Annual General Meeting
Notice is hereby given that the 110th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3, Level 34 North Tower, 80 Collins Street, Melbourne 3000 and online via Microsoft Teams, on Thursday, the 20th of October 2022 at 11:00am AEDT when the attendance of members is […]
